Dana Investment Advisors, Inc. Deciphera Pharmaceuticals, Inc. Transaction History

Dana Investment Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $69,380 - $88,692	5,109 Added 15.71%	37,622 $591,000
Q4 2023 Feb 07, 2024	SELL	$10.11 - $16.54 $26,902 - $44,012	-2,661 Reduced 7.57%	32,513 $524,000
Q3 2023 Nov 15, 2023	SELL	$12.46 - $15.48 $1,769 - $2,198	-142 Reduced 0.4%	35,174 $447,000
Q2 2023 Aug 15, 2023	BUY	$13.28 - $15.96 $11,553 - $13,885	870 Added 2.53%	35,316 $497,000
Q1 2023 May 15, 2023	SELL	$14.26 - $22.1 $14,160 - $21,945	-993 Reduced 2.8%	34,446 $532,000
Q4 2022 Feb 13, 2023	BUY	$14.85 - $19.04 $526,269 - $674,758	35,439 New	35,439 $580,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Dana Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Dana Investment Advisors, Inc. with notifications on news.